Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for SITAGLIPTIN

Ingredient

SITAGLIPTIN

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
JANUMET	1000MG 50MG	TABLET	Avoided shortage	2022-01-31	2022-03-06	153905
JANUMET	1000MG 50MG	TABLET	Resolved	2023-02-02	2023-02-07	183220
JANUMET	1000MG 50MG	TABLET	Resolved	2023-03-15	2023-03-18	187097
JANUMET XR	1000MG 50MG	TABLET (EXTENDED-RELEASE)	Resolved	2021-12-08	2021-12-14	150734
JANUMET XR	500MG 50MG	TABLET (EXTENDED-RELEASE)	Avoided shortage	2022-03-25	2022-04-18	157343
JANUMET XR	1000MG 50MG	TABLET (EXTENDED-RELEASE)	Avoided shortage	2022-03-25	2022-05-24	157340
JANUMET XR	1000MG 50MG	TABLET (EXTENDED-RELEASE)	Resolved	2023-07-07	2023-10-26	197795
JANUMET XR	1000MG 50MG	TABLET (EXTENDED-RELEASE)	Resolved	2023-11-08	2023-11-11	209562
JANUMET XR	1000MG 100MG	TABLET (EXTENDED-RELEASE)	Avoided shortage	2019-02-01	2019-02-27	74192
JANUMET XR	1000MG 100MG	TABLET (EXTENDED-RELEASE)	Resolved	2021-12-08	2021-12-15	150721

Previous
1
…
5
6
7
8
9
10
Next

Showing 61 to 70 of 98

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
JANUMET	850MG 50MG	TABLET	Discontinued	2024-12-12	2025-08-14	245516
STEGLUJAN	5MG 100MG	TABLET	Discontinued	2021-02-04	2021-02-04	133310
STEGLUJAN	15MG 100MG	TABLET	Discontinued	2021-02-04	2021-02-04	133307

1

Showing 1 to 3 of 3